The Wegovy pill, approved by the MHRA in June 2026, is the first oral GLP-1 weight loss tablet in the UK and contains the same active ingredient, semaglutide, as the Wegovy injection
(In addition to the shady Ozempic alternatives, the companies also advertise for generic alternatives to a variety of other weight loss products.) Found Health advertised their generic alternative to GLP-1 injections
Those blue-green cellular factories, labeled L-cells, are already poised to manufacture a powerful biological signal called GLP-1
The Ethics of Ozempic and Wegovy
Effect of xylazine sedation on testicular blood flow, testicular echotexture, and circulating hormones in Shiba goats
These findings prompted further investigation into the synthetic version of the peptide, now known as Epithalon, to better understand its mechanisms of action and potential applications in human health